Drugs / N,N-Dimethyltryptamine
Trials 11 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 18 trials | ||||||
| Phase 1 | NCT07693257 | Sep 2026 → Sep 2028 expected | — | Jon Dean | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT06180759 | Jan → Sep 2025 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 1 | NCT05695495 | Jun 2024 → Feb 2025 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 1 | NCT06252506 | Jan 2024 → Feb 2025 | — | Insel Gruppe AG, University Hospital Bern | Completed | No outcome recorded |
| Phase 1 | NCT05901012 | Apr → Jul 2023 | — | Federal University of Rio Grande do Norte | Completed | No outcome recorded |
| Phase 1 | NCT05559931 | Jan 2023 → Mar 2026 overdue | stroke disorder | Algernon Pharmaceuticals | Active not recruiting | No outcome recorded |
| Phase 1 | NCT05384678 | Nov 2022 → Mar 2024 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 1 | NCT05573568 | Jun → Nov 2022 | — | Biomind Labs Inc. | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT07562191 | Aug 2026 → Feb 2027 expected | major depressive disorder | Federal University of Rio Grande do Norte | Recruiting | No outcome recorded |
| Phase 2 | NCT06094907 | Oct 2023 → Jan 2024 | depressive disorder | Federal University of Rio Grande do Norte | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06927076 | Aug 2025 → Mar 2029 expected | major depressive disorder | University Hospital, Basel, Switzerland | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N,N-Dimethyltryptamine | “N,N-dimethyltryptamine (DMT) is a classical psychedelic” NCT06180759 ↗ |
| Known as | DMT | “Classical psychedelics such as N,N-dimethyltryptamine (DMT) modulate consciousness via serotonergic receptor agonism” PMID 42220002 ↗ Jun 20263“N,N-dimethyltryptamine (DMT) is a psychoactive substance with similar effects such as LSD or psilocybin.” NCT05384678 ↗ “N,N-dimethyltryptamine (DMT) is a psychoactive substance” NCT05695495 ↗ “N,N-dimethyltryptamine (DMT) is a classical psychedelic” NCT06180759 ↗ |
| Action | Activate | “DMT) modulate consciousness via serotonergic receptor agonism” PMID 42220002 ↗ Jun 2026 |
| Route | Intravenous | “different continuous intravenous DMT dose rates” NCT05384678 ↗ |